Swiss Life Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $346K | Sell |
|
|||||
|
2025
Q2 | $393K | Buy |
|
|||||
|
2025
Q1 | $319K | Sell |
|
|||||
|
2024
Q4 | $613K | Buy |
|
|||||
|
2024
Q3 | $209K | Sell |
|
|||||
|
2024
Q2 | $251K | Sell |
|
|||||
|
2024
Q1 | $439K | Sell |
|
|||||
|
2023
Q4 | $507K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.18M | Hold |
|
|||||
|
2023
Q1 | $2.09M | Buy |
|
|||||
|
2022
Q4 | $1.01M | Sell |
|
|||||
|
2022
Q3 | $1.18M | Sell |
|
|||||
|
2022
Q2 | $1.29M | Sell |
|
|||||
|
2022
Q1 | $2.33M | Buy |
|